A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.

Inclusion Criteria Patients must have: * Recent HIV infection. * No prior antiretroviral therapy. * No acute opportunistic infection at study entry. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: * Intractable diarrhea. * Bilateral peripheral neuropathy. * Any other condition that would preclude study therapy. Concurrent Medication: Excluded: * Myelosuppressive, neurotoxic, or hepatotoxic drugs. Patients with the following prior condition are excluded: History of bilateral peripheral neuropathy. Prior Medication: Excluded: * Prior antiretroviral therapy. * Myelosuppressive, neurotoxic, or cytotoxic agents within 3 months prior to study entry.